Hungary’s Richter completes contraceptive acquisition

Janssen’s transdermal patch to be sold outside the U.S.

Hungary Richter inks deal on drug sale in Latin America

Aims to become a global women's healthcare player

CHMP recommends restricting the use of Richter's Esmya

Ball now in European Commission's court

Hungary Richter stakeholder crosses north of 5% threshold

Orbán lists 11 successful Hungarian companies

Defends COVID-19 testing practices

Hungary to go on with COVID drug trial

Remdesivir research continues despite WHO statement

WHO finding is a cold shower: remdesivir has no substantial effect on COVID-19 patient's survival

Results of Solidarity trial leaked

Hungary Richter inks licence deal with Japan's Mochida

ANALYST VIEW - Drug of Hungary's Richter could be facing new rival

Jefferies publishes opinion

Wood takes the lead in Budapest bourse in August

Czech brokerage takes bigger bite of smaller pie

Hungarian state ownership in Richter decreases

Share transfer to foundation closed

ANALYST VIEW - Jefferies ups target price for Hungary's Richter

Share price close to all-time high

Richter receives marketing authorisation for Libdree in UK

Hungary Richter Q2 results beat expectations

Vraylar sales skyrockets, revenue rises

Eximbank to help Hungarian firms enter Uzbekistan with USD 95 mn credit line

Foreign Minister sees "extraordinary economic opportunities" in Uzbekistan

ANALYST VIEW - Jefferies reviews Richter 'wonder' drug

Vraylar sequential growth to continue after lockdown

Here's the latest ranking of Hungarian brokerages

Wood remains on throne in June

ANALYST VIEW - J.P. Morgan cuts target price for Hungary's Richter

Rating is overweight

Brokerage ranking has Wood on top again

Turnover drops in May after rally in March and April

Hungary Richter pays HUF 11.74 billion dividend

HUF 63.06 per share